Published in Med Hypotheses on January 19, 2007
Analgesic and antiinflammatory effects of cannabinoid receptor agonists in a rat model of neuropathic pain. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.84
Pain patterns and descriptions in patients with radicular pain: does the pain necessarily follow a specific dermatome? Chiropr Osteopat (2009) 0.83
Effect of Preoperative Inflammatory Status and Comorbidities on Pain Resolution and Persistent Postsurgical Pain after Inguinal Hernia Repair. Mediators Inflamm (2016) 0.80
The Role of C Fibers in Spinal Microglia Induction and Possible Relation with TRPV3 Expression During Chronic Inflammatory Arthritis in Rats. Basic Clin Neurosci (2016) 0.75
Dexmedetomidine Analgesia Effects in Patients Undergoing Dental Implant Surgery and Its Impact on Postoperative Inflammatory and Oxidative Stress. Oxid Med Cell Longev (2015) 0.75
Sciatica: detection and confirmation by new method. Int J Spine Surg (2014) 0.75
Adenosine for postoperative analgesia: A systematic review and meta-analysis. PLoS One (2017) 0.75
Challenges in translational drug research in neuropathic and inflammatory pain: the prerequisites for a new paradigm. Eur J Clin Pharmacol (2017) 0.75
Effects of anaesthesia and analgesia on long-term outcome after total knee replacement: A prospective, observational, multicentre study. Eur J Anaesthesiol (2017) 0.75
Relationship between Sleep, Pain and Inflammatory Markers in Patients with Rheumatoid Arthritis. J Caring Sci (2017) 0.75
Pain mechanisms: a new theory. Science (1965) 24.47
A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med (2002) 16.75
Magnetic resonance imaging of the lumbar spine in people without back pain. N Engl J Med (1994) 11.46
Abnormal magnetic-resonance scans of the lumbar spine in asymptomatic subjects. A prospective investigation. J Bone Joint Surg Am (1990) 8.22
Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med (2000) 5.64
Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science (1992) 5.18
Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature (2001) 4.82
Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum (1988) 4.60
Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med (2000) 4.06
Interleukin-6 in biology and medicine. Adv Immunol (1993) 4.06
Pain terms: a list with definitions and notes on usage. Recommended by the IASP Subcommittee on Taxonomy. Pain (1979) 3.82
The induction of pain: an integrative review. Prog Neurobiol (1999) 3.70
Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci U S A (1993) 3.29
IL-6 is produced by osteoblasts and induces bone resorption. J Immunol (1990) 3.14
Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res (1996) 2.86
Autologous nucleus pulposus induces neurophysiologic and histologic changes in porcine cauda equina nerve roots. Spine (Phila Pa 1976) (1993) 2.62
Interleukin-1 receptor antagonist. Adv Immunol (1993) 2.58
17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest (1992) 2.43
Inflammatory mediators of pain. Br J Anaesth (1995) 1.84
Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. J Clin Invest (1995) 1.79
Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone. J Clin Invest (1992) 1.78
IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol (1990) 1.77
Pain: past, present and future. Can J Exp Psychol (1993) 1.69
Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun (1989) 1.64
Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma (1999) 1.55
Reduction in potassium currents in identified cutaneous afferent dorsal root ganglion neurons after axotomy. J Neurophysiol (1999) 1.51
Cellular mechanisms and the role of cytokines in bone erosions in rheumatoid arthritis. Arthritis Rheum (2000) 1.47
Central hyperexcitability triggered by noxious inputs. Curr Opin Neurobiol (1993) 1.34
Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryot Gene Expr (1997) 1.33
Molecular and cellular biology of interleukin-6 and its receptor. Front Biosci (1996) 1.30
Cytokine involvement in dynorphin-induced allodynia. Pain (2000) 1.29
Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat. Exp Neurol (2001) 1.29
Natural history of individuals with asymptomatic disc abnormalities in magnetic resonance imaging: predictors of low back pain-related medical consultation and work incapacity. Spine (Phila Pa 1976) (2000) 1.27
The molecular pathophysiology of pain: abnormal expression of sodium channel genes and its contributions to hyperexcitability of primary sensory neurons. Pain (1999) 1.22
Spinal cord pharmacology of pain. Br J Anaesth (1995) 1.20
Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: possible immune modulation in neuropathic pain. Brain Res (2000) 1.19
Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6. J Bone Miner Res (1995) 1.17
Evidence for an autocrine/paracrine role for interleukin-6 in bone resorption by giant cells from giant cell tumors of bone. Endocrinology (1992) 1.17
Pathogenesis of sciatic pain: role of herniated nucleus pulposus and deformation of spinal nerve root and dorsal root ganglion. Pain (1998) 1.14
Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice. J Rheumatol (1995) 1.09
Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis. Arthritis Res (2000) 1.08
Gate control theory of pain stands the test of time. Br J Anaesth (2002) 1.08
Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons from postnatal rats. Neurosci Lett (1989) 1.07
Progressive rise in the expression of interleukin-6 in human endometrium during menstrual cycle is initiated during the implantation window. Hum Reprod (1995) 1.00
Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption. J Clin Invest (1995) 0.98
Adrenergic innervation of rat sensory ganglia following proximal or distal painful sciatic neuropathy: distinct mechanisms revealed by anti-NGF treatment. Eur J Neurosci (1999) 0.98
Differential effects of NGF and BDNF on axotomy-induced changes in GABA(A)-receptor-mediated conductance and sodium currents in cutaneous afferent neurons. J Neurophysiol (1997) 0.98
Incision of the anulus fibrosus induces nerve root morphologic, vascular, and functional changes. An experimental study. Spine (Phila Pa 1976) (1996) 0.97
NF-kappa B decoy suppresses cytokine expression and thermal hyperalgesia in a rat neuropathic pain model. Neuroreport (2001) 0.96
NGF has opposing effects on Na+ channel III and SNS gene expression in spinal sensory neurons. Neuroreport (1997) 0.94
Neuropathic pain: nerves bursting with excitement ... Neuroreport (2000) 0.92
Interleukin-6-type cytokines. Ann N Y Acad Sci (1995) 0.90
Interleukin-1beta induces interleukin-6 production through the production of prostaglandin E(2) in human osteoblasts, MG-63 cells. J Biochem (1999) 0.89
Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter. Cancer Lett (1996) 0.89
[Osteoporosis associated with rheumatoid arthritis]. Nihon Rinsho (2003) 0.76
[A breakthrough in the research on pain. Survey of the synaptic network may result in new analgesics]. Lakartidningen (1997) 0.76
Pathophysiological mechanisms of fibromyalgia. Clin J Pain (1991) 0.76